High Risk Primary Percutaneous Coronary Intervention (Pci) in Patient with Acute Stemi Anterior, Chronic Kidney Disease, and Confirmed Covid-19

Dede Moeswir, Fadhil Muhammad, Putri Nurbaeti

Abstract


Background: An acute ST-elevation myocardial infarction (STEMI) anterior occurs due to occlusion of left anterior descending artery (LAD) branch of left coronary artery. The occlusion causing transmural myocardial ischemia which in turn to myocardial infarction due to myocardial injury or necrosis. Not only Primary Percutaneous Coronary Intervention (PCI) should be performed in STEMI less than 120 minutes as the risk of the adverse events would increase if exceeding the total ischemic time, but also the procedure can be high risk in patients with multiple clinical factors or comorbidities which can increase the risk of complications.

Case Report: We report a case of a 57 years old man who presented Acute STEMI Anterior, Coronary Artery Disease (CAD) 3 Vessel Diseases (VD), Hypertension Heart Disease (HHD), Chronic Kidney Disease (CKD) on Hemodialysis (HD), with COVID-19 confirmed.

Results: The left coronary artery was successfully stented by PCI and Coronary Angiogram (CAG) procedures with TIMI 3 flow, minimal bleeding and others complications.


Keywords


ST-elevation myocardial infarction, Percutaneous Coronary Intervention (PCI), Chronic Kidney Disease on Hemodialysis, COVID-19

Full Text:

PDF

References


Gupta MD, Mp G, Kategari A, Batra V, Gupta P, Bansal A, et al. Epidemiological profile and management patterns of acute myocardial infarction in very young patients from a tertiary care center. Indian Heart J. 2020;72(1):32-9.

Chan MY, Du X, Eccleston D, Ma C, Mohanan PP, Ogita M, et al. Acute coronary syndrome in the Asia-Pacific region. Int J Cardiol. 2016;202:861-9.

Hina A et al. Acute ST Elevation Myocardial Infarction. StatPearls Publishing. 2021 [cited 2021 Nov 30]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532281/.

Wasilewski J, Niedziela J, Osadnik T, Duszanska A, Sraga W, Desperak P, et al. Predominant location of coronary artery atherosclerosis in the left anterior descending artery. The impact of septal perforators and the myocardial bridging effect. Kardiochir Torakochirurgia Pol. 2015;12(4):379-85.

Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852-66.

Stephen JM and William FG. Patofisiologi Penyakit Pengantar Menuju Kedokteran Klinis Ed 5. Jakarta: EGC. 2010. ISBN: 979-044-089-0.

Bittl JA. Percutaneous coronary interventions in the diabetic patient: where do we stand? Circ Cardiovasc Interv. 2015;8(4):e001944.

McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51(15):1419-28.

Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14(3):106-16.

Doll JA, Hira RS, Kearney KE, Kandzari DE, Riley RF, Marso SP, et al. Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference. Circ Cardiovasc Interv. 2020;13(6):e008962.

American Heart Association's Mission L, Get With The Guidelines Coronary Artery Disease Advisory Work G, the Council on Clinical Cardiology's Committees on Acute Cardiac C, General C, Interventional Cardiovascular C. Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA's Mission: Lifeline. Circulation. 2020;142(3):199-202.

Liang XY, Shang YS, Bai N, Zhong PY, Zhang WJ, Wang ZL. Management of acute coronary syndrome in the context of coronavirus disease 2019. Medicine (Baltimore). 2021;100(1):e24151.

Smith SC, Jr., Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001;103(24):3019-41.

The European Society for the Cardiology. ESC Guidance for The Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 2020 [cited 2021 Nov 30]. Available from: https://www.escardio.org/static-file/Escardio/Education-General/Topic%20pages/Covid-19/ESC%20Guidance%20Document/ESC-Guidance-COVID-19-Pandemic.pdf.

Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, et al. Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. J Am Heart Assoc. 2019;8(23):e014096.

Mansoor A et al. Percutaneous Coronary Intervention. StatPearls Publishing. 2021 2020 [cited 2021 Nov 30]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556123/.




DOI: https://doi.org/10.15408/avicenna.v2i2.23931 Abstract - 0 PDF - 0

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

View My Stats